Clinical Trial Update: Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study by Sanofi Pasteur evaluating the safety and immunogenicity of dengue vaccine formulations i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever
• Dengue Hemorrhagic Fever

Drugs mentioned

• Dengue vaccine formulations

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue Virus, Dengue Fever | Phase 2 | Status: COMPLETED